The crucial role of predicting brain metastases development in non-small cell lung cancer patients

被引：3
|
作者：
Addeo, Alfredo [1 ]
Banna, Giuseppe Luigi [2 ]
机构：
[1] Univ Hosp Geneva, Oncol Dept, CH-1205 Geneva, Switzerland
[2] Cannizzaro Hosp, Div Med Oncol, Via Messina 829, Catania, Italy
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
CHEMOTHERAPY;
D O I：
10.21037/jtd.2018.08.95
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S3305 / S3307
页数：3
相关论文
共 50 条
  • [41] ANALYSIS OF GEFITINIB ON BRAIN METASTASES IN PATIENTS WITH NON-SMALL LUNG CANCER
    Baihao, H.
    RESPIROLOGY, 2011, 16 : 132 - 132
  • [42] Factors predicting silent brain metastases in patients with non-small-cell lung cancer
    Na, I.
    Lee, T.
    Choe, D.
    Kang, H.
    Koh, J.
    Park, J.
    Baek, H.
    Kim, C.
    Ryoo, B.
    Lee, J.
    Yang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer
    Tummarello, D
    Lippe, P
    Bracci, R
    Mari, D
    Monterubbianesi, MC
    Battelli, N
    ONCOLOGY REPORTS, 1998, 5 (04) : 897 - 900
  • [44] Lowered Whole Brain Irradiation Dose for Non-Small Cell Lung Cancer Patients with Brain Metastases
    Wang, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S757 - S757
  • [45] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    LUNG CANCER, 2019, 129 : 35 - 40
  • [46] THE ADMINISTRATION OF BEVACIZUMAB FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES
    Fukunaga, Kentaro
    Kawashima, Satoru
    Yoshihashi, Saiko
    Seto, Ruriko
    Kanda, Rie
    Higami, Yuichi
    Goto, Kenichi
    Ryujin, Yasushi
    Nakagawa, Hiroaki
    Van Tho, Nguyen
    Yamaguchi, Masafumi
    Oguma, Tetuya
    Nagao, Taishi
    Ogawa, Emiko
    Nakano, Yasutaka
    RESPIROLOGY, 2013, 18 : 87 - 87
  • [47] Incidence and therapy of brain metastases in patients with locally advanced non-small cell lung cancer
    Zemanova, M
    Zatloukal, P
    Petruzelka, L
    Havel, L
    LUNG CANCER: CURRENT TOPICS, 2001, : 285 - 290
  • [48] Cytokines and chemokines as predictive markers in non-small cell lung cancer patients with brain metastases
    Altundag, O
    Altundag, K
    Morandi, P
    Gunduz, M
    LUNG CANCER, 2005, 47 (02) : 291 - 292
  • [49] Economic burden of brain metastases in patients with non-small cell lung cancer: costs and implications
    Chan, Po-Chung
    Rodrigues, Marjorie Monteiro
    Lim, Fiona Mei-Ying
    Chow, Edward
    Lo, Sing-Hung
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (02) : 210 - 214
  • [50] Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
    Tsakonas, G.
    Skribek, M.
    Kamali, C.
    Zerdes, I.
    Johannsdottir, B.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S599 - S599
12345